Semen parameters are unrelated to BMI but vary with SSRI use and prior urological surgery

Rachna Relwani, Dara Berger, Nanette Santoro, Cheryl Hickmon, Michael Nihsen, Athena Zapantis, Michael Werner, Alex J. Polotsky, Sangita K. Jindal

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Background: Male infertility affects approximately 6% of reproductive-aged men. It has been suggested that overweight men or men with obese body mass index (BMI) experience prolonged time to pregnancy, though the influence of male BMI on fertility remains understudied. Aims: We hypothesized that BMI is inversely correlated with fertility, manifested by reduced sperm concentration, motility, and morphology. Methods: Males of age 18 to 50 with semen analyses and self-reported BMI were included (n = 530). Patient parameters analyzed included age, BMI, smoking, urological, and fertility history. Leutinizing hormone (LH), Follicle-stimulating hormone, testosterone, steroid hormone-binding globulin (SHBG) and free androgen index (FAI) levels (n = 55), and selective serotonin reuptake inhibitor (SSRI) use (n = 12) were also measured. Results: The men in this study had a mean BMI of 28.2 ± 4.9 kg/m2 (range = 15-60), which is considered overweight, and a mean semen concentration of 55.4 ± 46.8 million/mL, which is in normal range, according to WHO standard. No consistent relationship was observed between increasing BMI and sperm concentration, motility, or morphology, although the testosterone levels trended downward with increasing BMI; there was a suggestion for decreased sperm concentration in current smokers. Men treated with combination SSRI and other psychotropic agent therapy (n = 12) had significantly reduced sperm motility (P =.009). Not unexpectedly, prior urological surgery (n = 77) was associated with lower sperm concentration (P =.0001) and morphology (P =.0008). When in vitro fertilization-embryo transfer (IVF-ET) was used as a treatment modality (n = 121), male BMI was not a significant predictor of clinical pregnancy (P =.06). Conclusions: In our study, we did not observe a significant association between male BMI and sperm concentration, motility or morphology, or clinical pregnancy following IVF-ET. Significantly, SSRI use may affect sperm parameters negatively.

Original languageEnglish (US)
Pages (from-to)391-397
Number of pages7
JournalReproductive Sciences
Volume18
Issue number4
DOIs
StatePublished - Apr 2011

Fingerprint

Serotonin Uptake Inhibitors
Semen
Body Mass Index
Sperm Motility
Fertility
Spermatozoa
Embryo Transfer
Fertilization in Vitro
Testosterone
Time-to-Pregnancy
Hormones
Pregnancy
Semen Analysis
Male Infertility
Globulins
Follicle Stimulating Hormone
Androgens
Reference Values
Smoking
Steroids

Keywords

  • BMI
  • fertility
  • male
  • semen
  • sperm
  • SSRI

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Semen parameters are unrelated to BMI but vary with SSRI use and prior urological surgery. / Relwani, Rachna; Berger, Dara; Santoro, Nanette; Hickmon, Cheryl; Nihsen, Michael; Zapantis, Athena; Werner, Michael; Polotsky, Alex J.; Jindal, Sangita K.

In: Reproductive Sciences, Vol. 18, No. 4, 04.2011, p. 391-397.

Research output: Contribution to journalArticle

Relwani, R, Berger, D, Santoro, N, Hickmon, C, Nihsen, M, Zapantis, A, Werner, M, Polotsky, AJ & Jindal, SK 2011, 'Semen parameters are unrelated to BMI but vary with SSRI use and prior urological surgery', Reproductive Sciences, vol. 18, no. 4, pp. 391-397. https://doi.org/10.1177/1933719110385708
Relwani, Rachna ; Berger, Dara ; Santoro, Nanette ; Hickmon, Cheryl ; Nihsen, Michael ; Zapantis, Athena ; Werner, Michael ; Polotsky, Alex J. ; Jindal, Sangita K. / Semen parameters are unrelated to BMI but vary with SSRI use and prior urological surgery. In: Reproductive Sciences. 2011 ; Vol. 18, No. 4. pp. 391-397.
@article{64388d12e57c4680a56dc1ae21b6ed74,
title = "Semen parameters are unrelated to BMI but vary with SSRI use and prior urological surgery",
abstract = "Background: Male infertility affects approximately 6{\%} of reproductive-aged men. It has been suggested that overweight men or men with obese body mass index (BMI) experience prolonged time to pregnancy, though the influence of male BMI on fertility remains understudied. Aims: We hypothesized that BMI is inversely correlated with fertility, manifested by reduced sperm concentration, motility, and morphology. Methods: Males of age 18 to 50 with semen analyses and self-reported BMI were included (n = 530). Patient parameters analyzed included age, BMI, smoking, urological, and fertility history. Leutinizing hormone (LH), Follicle-stimulating hormone, testosterone, steroid hormone-binding globulin (SHBG) and free androgen index (FAI) levels (n = 55), and selective serotonin reuptake inhibitor (SSRI) use (n = 12) were also measured. Results: The men in this study had a mean BMI of 28.2 ± 4.9 kg/m2 (range = 15-60), which is considered overweight, and a mean semen concentration of 55.4 ± 46.8 million/mL, which is in normal range, according to WHO standard. No consistent relationship was observed between increasing BMI and sperm concentration, motility, or morphology, although the testosterone levels trended downward with increasing BMI; there was a suggestion for decreased sperm concentration in current smokers. Men treated with combination SSRI and other psychotropic agent therapy (n = 12) had significantly reduced sperm motility (P =.009). Not unexpectedly, prior urological surgery (n = 77) was associated with lower sperm concentration (P =.0001) and morphology (P =.0008). When in vitro fertilization-embryo transfer (IVF-ET) was used as a treatment modality (n = 121), male BMI was not a significant predictor of clinical pregnancy (P =.06). Conclusions: In our study, we did not observe a significant association between male BMI and sperm concentration, motility or morphology, or clinical pregnancy following IVF-ET. Significantly, SSRI use may affect sperm parameters negatively.",
keywords = "BMI, fertility, male, semen, sperm, SSRI",
author = "Rachna Relwani and Dara Berger and Nanette Santoro and Cheryl Hickmon and Michael Nihsen and Athena Zapantis and Michael Werner and Polotsky, {Alex J.} and Jindal, {Sangita K.}",
year = "2011",
month = "4",
doi = "10.1177/1933719110385708",
language = "English (US)",
volume = "18",
pages = "391--397",
journal = "Reproductive Sciences",
issn = "1933-7191",
publisher = "SAGE Publications Inc.",
number = "4",

}

TY - JOUR

T1 - Semen parameters are unrelated to BMI but vary with SSRI use and prior urological surgery

AU - Relwani, Rachna

AU - Berger, Dara

AU - Santoro, Nanette

AU - Hickmon, Cheryl

AU - Nihsen, Michael

AU - Zapantis, Athena

AU - Werner, Michael

AU - Polotsky, Alex J.

AU - Jindal, Sangita K.

PY - 2011/4

Y1 - 2011/4

N2 - Background: Male infertility affects approximately 6% of reproductive-aged men. It has been suggested that overweight men or men with obese body mass index (BMI) experience prolonged time to pregnancy, though the influence of male BMI on fertility remains understudied. Aims: We hypothesized that BMI is inversely correlated with fertility, manifested by reduced sperm concentration, motility, and morphology. Methods: Males of age 18 to 50 with semen analyses and self-reported BMI were included (n = 530). Patient parameters analyzed included age, BMI, smoking, urological, and fertility history. Leutinizing hormone (LH), Follicle-stimulating hormone, testosterone, steroid hormone-binding globulin (SHBG) and free androgen index (FAI) levels (n = 55), and selective serotonin reuptake inhibitor (SSRI) use (n = 12) were also measured. Results: The men in this study had a mean BMI of 28.2 ± 4.9 kg/m2 (range = 15-60), which is considered overweight, and a mean semen concentration of 55.4 ± 46.8 million/mL, which is in normal range, according to WHO standard. No consistent relationship was observed between increasing BMI and sperm concentration, motility, or morphology, although the testosterone levels trended downward with increasing BMI; there was a suggestion for decreased sperm concentration in current smokers. Men treated with combination SSRI and other psychotropic agent therapy (n = 12) had significantly reduced sperm motility (P =.009). Not unexpectedly, prior urological surgery (n = 77) was associated with lower sperm concentration (P =.0001) and morphology (P =.0008). When in vitro fertilization-embryo transfer (IVF-ET) was used as a treatment modality (n = 121), male BMI was not a significant predictor of clinical pregnancy (P =.06). Conclusions: In our study, we did not observe a significant association between male BMI and sperm concentration, motility or morphology, or clinical pregnancy following IVF-ET. Significantly, SSRI use may affect sperm parameters negatively.

AB - Background: Male infertility affects approximately 6% of reproductive-aged men. It has been suggested that overweight men or men with obese body mass index (BMI) experience prolonged time to pregnancy, though the influence of male BMI on fertility remains understudied. Aims: We hypothesized that BMI is inversely correlated with fertility, manifested by reduced sperm concentration, motility, and morphology. Methods: Males of age 18 to 50 with semen analyses and self-reported BMI were included (n = 530). Patient parameters analyzed included age, BMI, smoking, urological, and fertility history. Leutinizing hormone (LH), Follicle-stimulating hormone, testosterone, steroid hormone-binding globulin (SHBG) and free androgen index (FAI) levels (n = 55), and selective serotonin reuptake inhibitor (SSRI) use (n = 12) were also measured. Results: The men in this study had a mean BMI of 28.2 ± 4.9 kg/m2 (range = 15-60), which is considered overweight, and a mean semen concentration of 55.4 ± 46.8 million/mL, which is in normal range, according to WHO standard. No consistent relationship was observed between increasing BMI and sperm concentration, motility, or morphology, although the testosterone levels trended downward with increasing BMI; there was a suggestion for decreased sperm concentration in current smokers. Men treated with combination SSRI and other psychotropic agent therapy (n = 12) had significantly reduced sperm motility (P =.009). Not unexpectedly, prior urological surgery (n = 77) was associated with lower sperm concentration (P =.0001) and morphology (P =.0008). When in vitro fertilization-embryo transfer (IVF-ET) was used as a treatment modality (n = 121), male BMI was not a significant predictor of clinical pregnancy (P =.06). Conclusions: In our study, we did not observe a significant association between male BMI and sperm concentration, motility or morphology, or clinical pregnancy following IVF-ET. Significantly, SSRI use may affect sperm parameters negatively.

KW - BMI

KW - fertility

KW - male

KW - semen

KW - sperm

KW - SSRI

UR - http://www.scopus.com/inward/record.url?scp=79955584969&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955584969&partnerID=8YFLogxK

U2 - 10.1177/1933719110385708

DO - 10.1177/1933719110385708

M3 - Article

VL - 18

SP - 391

EP - 397

JO - Reproductive Sciences

JF - Reproductive Sciences

SN - 1933-7191

IS - 4

ER -